These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 32712233)

  • 1. Hypoxia-driven intratumor heterogeneity and immune evasion.
    Terry S; Engelsen AST; Buart S; Elsayed WS; Venkatesh GH; Chouaib S
    Cancer Lett; 2020 Nov; 492():1-10. PubMed ID: 32712233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
    Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
    Chouaib S
    Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
    Noman MZ; Hasmim M; Messai Y; Terry S; Kieda C; Janji B; Chouaib S
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C569-79. PubMed ID: 26310815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response.
    Noman MZ; Messai Y; Carré T; Akalay I; Méron M; Janji B; Hasmim M; Chouaib S
    Crit Rev Immunol; 2011; 31(5):357-77. PubMed ID: 22142164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies.
    Qiu GZ; Jin MZ; Dai JX; Sun W; Feng JH; Jin WL
    Trends Pharmacol Sci; 2017 Aug; 38(8):669-686. PubMed ID: 28602395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
    Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
    Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
    Biswas A; De S
    Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-/HIF-1α-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression.
    Vaupel P; Multhoff G
    Adv Exp Med Biol; 2018; 1072():171-175. PubMed ID: 30178341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Hypoxia: A Key Determinant of Microenvironment Hostility and a Major Checkpoint during the Antitumor Response.
    Francis A; Venkatesh GH; Zaarour RF; Zeinelabdin NA; Nawafleh HH; Prasad P; Buart S; Terry S; Chouaib S
    Crit Rev Immunol; 2018; 38(6):505-524. PubMed ID: 31002604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity.
    Janji B; Berchem G; Chouaib S
    Front Immunol; 2018; 9():887. PubMed ID: 29922284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?
    Abou Khouzam R; Zaarour RF; Brodaczewska K; Azakir B; Venkatesh GH; Thiery J; Terry S; Chouaib S
    Front Immunol; 2022; 13():828875. PubMed ID: 35211123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic tumor microenvironment: Implications for cancer therapy.
    Roy S; Kumaravel S; Sharma A; Duran CL; Bayless KJ; Chakraborty S
    Exp Biol Med (Maywood); 2020 Jul; 245(13):1073-1086. PubMed ID: 32594767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.
    Scanlon SE; Glazer PM
    DNA Repair (Amst); 2015 Aug; 32():180-189. PubMed ID: 25956861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence.
    Vessoni AT; Filippi-Chiela EC; Lenz G; Batista LFZ
    Oncogene; 2020 Mar; 39(10):2055-2068. PubMed ID: 31801972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy.
    Abou Khouzam R; Janji B; Thiery J; Zaarour RF; Chamseddine AN; Mayr H; Savagner P; Kieda C; Gad S; Buart S; Lehn JM; Limani P; Chouaib S
    Semin Cancer Biol; 2023 Dec; 97():104-123. PubMed ID: 38029865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-Driven Immune Escape in the Tumor Microenvironment.
    Vito A; El-Sayes N; Mossman K
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imitating Hypoxia and Tumor Microenvironment with Immune Evasion by Employing Three Dimensional
    Ray SK; Mukherjee S
    Recent Pat Anticancer Drug Discov; 2022; 17(1):80-91. PubMed ID: 34323197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.
    Li C; Liu T; Bazhin AV; Yang Y
    J Cell Physiol; 2017 Sep; 232(9):2312-2322. PubMed ID: 27935039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia Mediates Tumor Malignancy and Therapy Resistance.
    Luo W; Wang Y
    Adv Exp Med Biol; 2019; 1136():1-18. PubMed ID: 31201713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.